Survival for 29 patients who had a resection of the diaphragm as part of the cytoreductive surgical procedure combined with hyperthermic intraoperative thoracoabdominal chemotherapy (HITAC). (a) appendiceal malignancy (), (b) peritoneal mesothelioma (), and (c) colon cancer ().